BPC 157: Miracle Healing Peptide or Hidden Danger? BPC 157: Experimental Peptide Creates Risk for Athletes The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA takes first step in possible reversal of ban on some peptides The Washington Post FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida